Thomas A. Fitzgerald

Chief Financial Officer, Transcode Therapeutics, Inc.

Companies

Transcode Therapeutics, Inc.Board member Jul 8, 2021 to now¹
Transcode Therapeutics, Inc.Chief financial officer Jul 8, 2021 to Sep 21, 2026¹
Transcode Therapeutics, Inc.Chief executive officer Jun 18, 2024 to Jun 18, 2024²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Transcode Therapeutics, Inc. RNAZ56,318 shares³$101.4K at $1.80Sep 28, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 28, 2023Bought 49,350 shares at $0.51 of Transcode Therapeutics, Inc.³
Jun 16, 2022Bought 12,000 shares at $1.27 of Transcode Therapeutics, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTranscode Therapeutics, Inc., Board member
2
SEC EDGARTranscode Therapeutics, Inc., Chief executive officer
3
SEC EDGARTranscode Therapeutics, Inc. shares after the filing of Sep 28, 2023
4
SEC EDGARForm 4 filed Jun 17, 2022